Tofacitinib Citrate

Grade: Pharmaceutical Grade

Factory Location: Guangan city ,Sichuan province, China

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Packaging Information: 25KG/Drum

Delivery Lead Time: 30 days

Sample Provided: yes

Payment Terms: T/T

Tofacitinib Citrate an inhibitor of Janus kinases (JAKs), is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs).